Wenxiang Ji
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 4
- MicroRNA in disease regulation 3
-
- Fibroblast Growth Factor Research 8
- Epigenetics and DNA Methylation 6
- Kruppel-like factors research 4
-
- Cancer Immunotherapy and Biomarkers 5
-
- Lung Cancer Treatments and Mutations 6
-
- Rangeland and Wildlife Management 2
- Journals
- Oncogene (2 papers)Science Translational Medicine (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaNew ZealandHong Kong
In The Last Decade
Wenxiang Ji
26 papers receiving 625 citations
Peers
Comparison fields: 5 of 90
- Cancer Research 230
- Molecular Biology 455
- Oncology 159
- Cell Biology 58
- Pulmonary and Respiratory Medicine 112
Countries citing papers authored by Wenxiang Ji
This map shows the geographic impact of Wenxiang Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenxiang Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenxiang Ji more than expected).
Fields of papers citing papers by Wenxiang Ji
This network shows the impact of papers produced by Wenxiang Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenxiang Ji. The network helps show where Wenxiang Ji may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wenxiang Ji, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 8 | |
| 2 | 2024 | 9 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 10 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 3 | |
| 8 | 2022 | 4 | |
| 9 | 2021 | 5 | |
| 10 | 2021 | 14 | |
| 11 | 2020 | 30 | |
| 12 | 2020 | 8 | |
| 13 | 2019 | 13 | |
| 14 | 2019 | 93 | |
| 15 | 2019 | 38 | |
| 16 | 2018 | 139 | |
| 17 | 2018 | 56 | |
| 18 | 2017 | 49 | |
| 19 | Guidelines for lung cancer in 2015: Consensus and controversy | 2016 | 1 |
| 20 | 2016 | 26 |
About Wenxiang Ji
Wenxiang Ji is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 26 papers that have together received 630 indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (8 papers), Epigenetics and DNA Methylation (6 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer Genomics and Diagnostics (4 papers), Kruppel-like factors research (4 papers), MicroRNA in disease regulation (3 papers) and Rangeland and Wildlife Management (2 papers). The work is most often cited by research in Cancer Research (230 citations), Molecular Biology (455 citations) and Oncology (159 citations). Wenxiang Ji has collaborated with scholars based in China, New Zealand and Hong Kong. Frequent co-authors include Weiliang Xia, Shun Lü, Ziming Li, Yongfeng Yu, Xiaomin Niu, Kaixuan Wang, Yongfeng Yu, Qingyu Zeng, Yirui Cheng and Ying Yang. Their work appears in journals such as Oncogene, Science Translational Medicine and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.